Skip to main content
. Author manuscript; available in PMC: 2011 Oct 10.
Published in final edited form as: Am J Transplant. 2008 Dec;8(12):2636–2646. doi: 10.1111/j.1600-6143.2008.02422.x

Table 3.

Cox's regression analysis of deceased-donor graft survival at five years among two-year survivors (N= 9,320).

Baseline Model
Variable Hazard Ratio 95% Confidence Limits P
Income Q1 1.362 1.230 1.508 <0.0001
Eligible 1.316 1.185 1.461 <0.0001
Post 1997 1.019 0.918 1.131 0.7202
Income Q1*Eligible*Post 1997 0.788 0.675 0.921 0.0026
Model Including Donor, Recipient, and Transplant Characteristics
Variable Hazard Ratio 95% Confidence Limits P
Income Q1 1.182 1.057 1.322 0.0034
Eligible 1.200 1.069 1.348 0.0020
Post 1997 1.033 0.925 1.153 0.5653
Income Q1*Eligible*Post 1997 0.806 0.687 0.947 0.0086
Black recipient 1.639 1.489 1.804 <0.0001
College-educated recipient 0.816 0.732 0.909 0.0002
Male donor 0.867 0.794 0.947 0.0016
CMV donor +/ recipient + 1.111 1.014 1.216 0.0232
CMV donor +/ recipient − 1.120 1.007 1.245 0.0365
Tacrolimus at discharge 0.837 0.748 0.937 0.0020
Delayed graft function 1.268 1.156 1.390 <0.0001

CMV, cytomegalovirus; Q, quartile

Variables found to be insignificant in the regression included: recipient sex, body mass index, and panel-reactive antibody >50%; donor race, body mass index; number of HLA mismatches, CMV donor −/ recipient + sero-pairing; discharge cyclosporine, and discharge MMF.